Zhiwei Quan

3.1k total citations
79 papers, 2.4k citations indexed

About

Zhiwei Quan is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Zhiwei Quan has authored 79 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Molecular Biology, 38 papers in Cancer Research and 32 papers in Surgery. Recurrent topics in Zhiwei Quan's work include Cancer-related molecular mechanisms research (27 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (26 papers) and RNA modifications and cancer (16 papers). Zhiwei Quan is often cited by papers focused on Cancer-related molecular mechanisms research (27 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (26 papers) and RNA modifications and cancer (16 papers). Zhiwei Quan collaborates with scholars based in China, Canada and Sweden. Zhiwei Quan's co-authors include Mingzhe Weng, Mingdi Zhang, Di Zhou, Qiang Cai, Jiandong Wang, Zhaohui Tang, Wei Gong, Xiaocai Wu, Shou-Hua Wang and Yiyu Qin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Zhiwei Quan

75 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiwei Quan China 28 1.8k 1.5k 436 284 200 79 2.4k
Lianxin Liu China 27 1.4k 0.8× 1.1k 0.7× 345 0.8× 533 1.9× 251 1.3× 59 2.5k
Chunyan Gu China 24 1.5k 0.8× 678 0.4× 368 0.8× 295 1.0× 133 0.7× 93 2.3k
Lin Jiang China 23 1.4k 0.8× 788 0.5× 313 0.7× 235 0.8× 97 0.5× 54 1.9k
Liang Han China 29 2.5k 1.4× 2.2k 1.5× 239 0.5× 300 1.1× 307 1.5× 58 2.9k
Beifang Ning China 23 1.4k 0.8× 929 0.6× 235 0.5× 509 1.8× 359 1.8× 36 2.2k
Qian Zhao China 31 2.4k 1.3× 1.6k 1.1× 226 0.5× 450 1.6× 236 1.2× 110 3.4k
Jian‐Hong Fang China 26 2.0k 1.1× 1.8k 1.2× 137 0.3× 361 1.3× 213 1.1× 43 2.9k
Zhi‐Qiang Ling China 30 1.6k 0.9× 894 0.6× 469 1.1× 465 1.6× 162 0.8× 117 2.6k
Fuqing Zeng China 24 2.0k 1.1× 1.5k 1.0× 195 0.4× 214 0.8× 91 0.5× 87 2.5k

Countries citing papers authored by Zhiwei Quan

Since Specialization
Citations

This map shows the geographic impact of Zhiwei Quan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiwei Quan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiwei Quan more than expected).

Fields of papers citing papers by Zhiwei Quan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiwei Quan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiwei Quan. The network helps show where Zhiwei Quan may publish in the future.

Co-authorship network of co-authors of Zhiwei Quan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiwei Quan. A scholar is included among the top collaborators of Zhiwei Quan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiwei Quan. Zhiwei Quan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Qing, Chang‐Jiu Li, Zhiwei Quan, et al.. (2025). Association between rheumatoid arthritis and periodontitis: a study based on a two-sample mendelian randomisation analysis. Medicina oral, patología oral y cirugía bucal. 30(3). e354–e362.
2.
Zhang, Yushi, et al.. (2025). Knowledge and perception of specialties of dentistry among undergraduatein the Northeast China. BMC Oral Health. 25(1). 588–588.
3.
Zhang, Kai, et al.. (2024). The New Perspectives Journal of Medicine. 1 indexed citations
4.
5.
Zhang, Mingdi, Yiyu Qin, Bin Zuo, et al.. (2017). Overexpression of NOTCH-regulated Ankyrin Repeat Protein is associated with papillary thyroid carcinoma progression. PLoS ONE. 12(2). e0167782–e0167782. 11 indexed citations
6.
Zhang, Mingdi, Shizhong Cai, Bin Zuo, et al.. (2017). Arctigenin induced gallbladder cancer senescence through modulating epidermal growth factor receptor pathway. Tumor Biology. 39(5). 3726131435–3726131435. 27 indexed citations
7.
Wei, Miaoyan, Pei‐Yi Lin, Zhisheng Chen, et al.. (2017). Integrated mRNA and lncRNA expression profiling for exploring metastatic biomarkers of human intrahepatic cholangiocarcinoma.. PubMed. 7(3). 688–699. 28 indexed citations
8.
Ma, Mingzhe, Yan Zhang, Mingzhe Weng, et al.. (2016). Long Noncoding RNA GCASPC , a Target of miR-17-3p, Negatively Regulates Pyruvate Carboxylase–Dependent Cell Proliferation in Gallbladder Cancer. Cancer Research. 76(18). 5361–5371. 77 indexed citations
9.
Ma, Mingzhe, Mingzhe Weng, Mingdi Zhang, et al.. (2015). Targeting gallbladder cancer: hyaluronan sensitizes cancer cells to chemo-therapeutics.. PubMed. 8(2). 1822–5. 5 indexed citations
10.
Fu, Binsheng, et al.. (2015). Yes-associated protein (YAP) expression is involved in epithelial–mesenchymal transition in hepatocellular carcinoma. Clinical & Translational Oncology. 18(2). 172–177. 28 indexed citations
11.
Zhuang, Peng–Yuan, et al.. (2015). Higher proliferation of peritumoral endothelial cells to IL-6/sIL-6R than tumoral endothelial cells in hepatocellular carcinoma. BMC Cancer. 15(1). 830–830. 16 indexed citations
12.
Wang, Jiandong, Jun Shen, Xueping Zhou, et al.. (2013). [Comprehensive measures for improving the radical resection rate and safety of Bismuth-Corlette type III hilar cholangiocarcinoma].. PubMed. 51(7). 596–9. 1 indexed citations
13.
Wang, Jiandong, Jun Shen, Xueping Zhou, et al.. (2011). Selection of range of regional lymphadenectomy for patients with T2 gallbladder cancer. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 10(2). 100–102. 1 indexed citations
14.
Wang, Chunfeng, Zhenyu Wang, Jing Ding, et al.. (2011). Preconditioning donor liver withNodosinperfusion lessens rat ischemia reperfusion injury via heme oxygenase‐1 upregulation. Journal of Gastroenterology and Hepatology. 27(4). 832–840. 19 indexed citations
15.
Wang, Jiandong, Xuefeng Wang, Yong Yang, et al.. (2010). Value of different staging systems for gallbladder cancer. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 9(2). 133–135. 1 indexed citations
16.
Liu, Yingbin, Ying Kong, Xuan Wang, et al.. (2008). Role of dissection of secondary branches of splenic pedicle in portal hypertension cases undergoing splenectomy. Chinese Medical Journal. 121(22). 2250–2253. 5 indexed citations
17.
Quan, Zhiwei. (2008). Clinical Analysis of 51 Cases of Gastric Stump Cancer after Subtotal Gastrectomy.
18.
Li, Jiyu, Zhiwei Quan, Qiang Zhang, & Jianwen Liu. (2007). The synergistic inhibitory effect of somatostatin-doxorubicin co-treatment on gallbladder carcinoma. BMC Cancer. 7(1). 125–125. 2 indexed citations
19.
Quan, Zhiwei. (2005). EFFECT OF SOMATOSTATIN ON THE CELL CYCLE OF HUMAN GALLBLADDER CANCER CELL. 1 indexed citations
20.
Li, Jiyu, Zhiwei Quan, Qiang Zhang, & Jianwen Liu. (2004). Somatostatin may enhance cytotoxic effect of doxorubicin on gallbladder cancer cells. Chinese Journal of Cancer Research. 16(4). 265–268. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026